Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy.

about

Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy.

Item

http://www.wikidata.org/entity/Q53648445

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@en

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@nl

type

Item

label

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@en

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@nl

prefLabel

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@en

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@nl

P1476

Serum interferon inhibitor dec ...... nge in antiretroviral therapy.

@en

P2093

Kailash C Chadha

http://www.w3.org/2001/XMLSchema#string

Lisa R Demeter

http://www.w3.org/2001/XMLSchema#string

Madhavan P N Nair

http://www.w3.org/2001/XMLSchema#string

Ross G Hewitt

http://www.w3.org/2001/XMLSchema#string

Stanley A Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV.

Cytokine therapeutics: lessons from interferon alpha

Interferon inhibitor factor predicting success of plasmapheresis in patients with multiple sclerosis.

Acid lability is not an intrinsic property of interferon-alpha induced by HIV-infected cells.

Effect of an interferon inhibitor on the antiproliferative signal of interferon-alpha.

Decreased frequency of functional natural interferon-producing cells in peripheral blood of patients with the acquired immune deficiency syndrome.

Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Interferon inactivator(s) in patients with AIDS and AIDS-unrelated Kaposi's sarcoma.

Interferon inhibitors in lupus erythematosus.

Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals.

P304

299-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/IMM-120025107

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14603996

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug